ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

December Business & Regulatory Report included in this issue.

December 12, 2003

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

NCI Cooperative Group Clinical Trials Approved

February 26, 2010

Broad Institute wins NIH grant for first national SNP genotyping center.

October 8, 2004

Cancer Act Renewals Marked By Disputes Over NCI Authorities

October 5, 1990

DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects

June 17, 1994